FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2261046711> ?p ?o ?g. }

• W2261046711 endingPage "275" @default.
• W2261046711 startingPage "275" @default.
• W2261046711 abstract "<h3>Importance</h3> Stent retrievers are a promising alternative for the treatment of acute ischemic stroke (AIS). Several recently completed clinical trials have examined the use of stent retrievers with intravenous recombinant tissue plasminogen activator (rtPA) compared with rtPA alone. <h3>Objective</h3> To conduct a systematic review and meta-analysis of randomized clinical trials to quantify the benefits and risks of using stent retrievers in addition to rtPA for the treatment of AIS. <h3>Data Sources</h3> The MEDLINE, EMBASE, and Cochrane Library of Clinical Trials databases were searched from inception to July 2015 for the keywords<i>stent*, retriev*, Solitaire, Trevo, Revive</i>, and<i>stroke</i>. Trial registries were also searched. A total of 326 publications were identified and 213 potentially relevant records were screened. <h3>Study Selection</h3> Randomized clinical trials that examined stent retrievers with rtPA vs rtPA alone were included in the meta-analysis. <h3>Data Extraction and Synthesis</h3> Two independent reviewers extracted study data and performed quality assessment using the Cochrane Risk of Bias Tool. DerSimonian and Laird random-effects models were used to estimate relative risks (RRs), risk differences (RDs), and numbers needed to treat. <h3>Main Outcomes and Measures</h3> The primary outcome was the proportion of patients achieving functional independence (defined as a score of 0-2 on the modified Rankin Scale, with 0 indicating no disability and 6 indicating death) at 90 days. Risks of all-cause mortality, intracranial hemorrhage, and parenchymal hematoma at 90 days were also assessed. <h3>Results</h3> Five randomized clinical trials met our inclusion criteria (n = 1287 patients). Patients randomized to stent-retriever therapy with rtPA had significantly improved rates of functional independence at 90 days compared with those randomized to rtPA alone (RR, 1.72; 95% CI, 1.48-1.99; RD, 0.19; 95% CI, 0.13-0.25). When data were pooled across trials, the effect of stent-retriever therapy on all-cause mortality at 90 days was inconclusive (RR, 0.82; 95% CI, 0.60-1.11; RD, −0.04; 95% CI, −0.08 to 0.1). There were similarly no detectable differences in the risks of intracranial hemorrhage (RR, 1.15; 95% CI, 0.67-1.97; RD, 0.00; 95% CI, −0.02 to 0.03) or parenchymal hematoma (RR, 1.18; 95% CI, 0.71-1.94; RD, 0.01; 95% CI, −0.01 to 0.04), although the 95% CIs were wide. Fixed-effects sensitivity analyses produced similar results for all outcomes. <h3>Conclusions and Relevance</h3> The use of stent retrievers in conjunction with rtPA vs rtPA alone is associated with significant improvement of functional independence 90 days after AIS." @default.
• W2261046711 created "2016-06-24" @default.
• W2261046711 creator A5019328184 @default.
• W2261046711 creator A5035765740 @default.
• W2261046711 creator A5042323998 @default.
• W2261046711 creator A5042964192 @default.
• W2261046711 creator A5051500083 @default.
• W2261046711 creator A5072116483 @default.
• W2261046711 date "2016-03-01" @default.
• W2261046711 modified "2023-10-15" @default.
• W2261046711 title "Stent Retrievers for the Treatment of Acute Ischemic Stroke" @default.
• W2261046711 cites W1492834429 @default.
• W2261046711 cites W2037399775 @default.
• W2261046711 cites W2052221403 @default.
• W2261046711 cites W2084521665 @default.
• W2261046711 cites W2093072754 @default.
• W2261046711 cites W2098923148 @default.
• W2261046711 cites W2101092086 @default.
• W2261046711 cites W2113180695 @default.
• W2261046711 cites W2113639345 @default.
• W2261046711 cites W2119542322 @default.
• W2261046711 cites W2134004558 @default.
• W2261046711 cites W2139621750 @default.
• W2261046711 cites W2143237216 @default.
• W2261046711 cites W2150215887 @default.
• W2261046711 cites W2153664287 @default.
• W2261046711 cites W2156098321 @default.
• W2261046711 cites W2171058244 @default.
• W2261046711 cites W2171165037 @default.
• W2261046711 cites W2193244909 @default.
• W2261046711 cites W2468996569 @default.
• W2261046711 cites W2470750097 @default.
• W2261046711 cites W2991792334 @default.
• W2261046711 cites W2169742106 @default.
• W2261046711 doi "https://doi.org/10.1001/jamaneurol.2015.4441" @default.
• W2261046711 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26810499" @default.
• W2261046711 hasPublicationYear "2016" @default.
• W2261046711 type Work @default.
• W2261046711 sameAs 2261046711 @default.
• W2261046711 citedByCount "50" @default.
• W2261046711 countsByYear W22610467112016 @default.
• W2261046711 countsByYear W22610467112017 @default.
• W2261046711 countsByYear W22610467112018 @default.
• W2261046711 countsByYear W22610467112019 @default.
• W2261046711 countsByYear W22610467112020 @default.
• W2261046711 countsByYear W22610467112021 @default.
• W2261046711 countsByYear W22610467112022 @default.
• W2261046711 countsByYear W22610467112023 @default.
• W2261046711 crossrefType "journal-article" @default.
• W2261046711 hasAuthorship W2261046711A5019328184 @default.
• W2261046711 hasAuthorship W2261046711A5035765740 @default.
• W2261046711 hasAuthorship W2261046711A5042323998 @default.
• W2261046711 hasAuthorship W2261046711A5042964192 @default.
• W2261046711 hasAuthorship W2261046711A5051500083 @default.
• W2261046711 hasAuthorship W2261046711A5072116483 @default.
• W2261046711 hasBestOaLocation W22610467111 @default.
• W2261046711 hasConcept C126322002 @default.
• W2261046711 hasConcept C127413603 @default.
• W2261046711 hasConcept C141071460 @default.
• W2261046711 hasConcept C168563851 @default.
• W2261046711 hasConcept C17744445 @default.
• W2261046711 hasConcept C190659310 @default.
• W2261046711 hasConcept C199539241 @default.
• W2261046711 hasConcept C2776478404 @default.
• W2261046711 hasConcept C2778583881 @default.
• W2261046711 hasConcept C2779473830 @default.
• W2261046711 hasConcept C2780645631 @default.
• W2261046711 hasConcept C2780931571 @default.
• W2261046711 hasConcept C3020199598 @default.
• W2261046711 hasConcept C535046627 @default.
• W2261046711 hasConcept C541997718 @default.
• W2261046711 hasConcept C71924100 @default.
• W2261046711 hasConcept C78519656 @default.
• W2261046711 hasConcept C95190672 @default.
• W2261046711 hasConceptScore W2261046711C126322002 @default.
• W2261046711 hasConceptScore W2261046711C127413603 @default.
• W2261046711 hasConceptScore W2261046711C141071460 @default.
• W2261046711 hasConceptScore W2261046711C168563851 @default.
• W2261046711 hasConceptScore W2261046711C17744445 @default.
• W2261046711 hasConceptScore W2261046711C190659310 @default.
• W2261046711 hasConceptScore W2261046711C199539241 @default.
• W2261046711 hasConceptScore W2261046711C2776478404 @default.
• W2261046711 hasConceptScore W2261046711C2778583881 @default.
• W2261046711 hasConceptScore W2261046711C2779473830 @default.
• W2261046711 hasConceptScore W2261046711C2780645631 @default.
• W2261046711 hasConceptScore W2261046711C2780931571 @default.
• W2261046711 hasConceptScore W2261046711C3020199598 @default.
• W2261046711 hasConceptScore W2261046711C535046627 @default.
• W2261046711 hasConceptScore W2261046711C541997718 @default.
• W2261046711 hasConceptScore W2261046711C71924100 @default.
• W2261046711 hasConceptScore W2261046711C78519656 @default.
• W2261046711 hasConceptScore W2261046711C95190672 @default.
• W2261046711 hasIssue "3" @default.
• W2261046711 hasLocation W22610467111 @default.
• W2261046711 hasLocation W22610467112 @default.
• W2261046711 hasOpenAccess W2261046711 @default.
• W2261046711 hasPrimaryLocation W22610467111 @default.
• W2261046711 hasRelatedWork W1509374478 @default.

• next